Aims: To determine if massive pulmonary platelet thromboembolism is a common cause of peroperative death following liver transplantation; and to compare the incidence of this event with patients dying after non-transplantation procedures. Methods: Necropsy tissues from all patients dying within 10 days of operation during the past three and a half years were studied (six liver transplantations and 13 unrelated operations). Haematoxylin and eosin stained sections of all tissues were examined. Additional sections of lung tissue were immunostained for constituents of thrombus (fibrin and platelets). Results: At necropsy the lungs from all six liver transplant recipients were heavy with a rubbery texture and little oedema fluid. Those from non-transplantation patients appeared normal or very oedematous. Microscopic examination showed that there were numerous platelet aggregates occluding pulmonary capillaries in all six transplant recipients, but in only three of the non-transplant patients. These thrombi were numerous in patients dying during surgery and the number was underestimated in routine sections because of the surrounding capillary congestion. Detection was improved by immunostaining for platelets with factor XIIIA and platelet glycoprotein IIIa. Conclusions: Massive platelet thromboembolism is a likely cause of death in patients dying unexpectedly following recent liver transplantation. Non-transplantation patients dying during surgery who show similar appearances usually have conditions known to have a high risk of thrombosis or embolism (cement hypotension syndrome and disseminated intravascular coagulation). The cause of this extensive platelet activation in liver transplant recipients is uncertain and may be multifactorial. The unusual rubbery consistency of the lungs on macroscopic examination could alert the pathologist to the underlying condition. Immunostaining for platelets improves the detection microscopically. Liver transplantation is performed with considerable success in many centres throughout the world. In over 100 adult orthotopic liver transplantations carried out at the Royal Free Hospital there have been minimal surgical complications but three patients died unexpectedly during the operation. At necropsy numerous platelet aggregates were found occluding pulmonary capillaries. Similar platelet thrombi were recently described in the lungs of children dying during liver transplantation. ' Although pulmonary microembolism is a recognised complication of several conditions including disseminated intravascular coagulation (DIC), multiple trauma and major orthopaedic and vascular surgery,23 an association with transplantation has not been widely established. It is also unknown if platelet thrombi are found more commonly in liver transplant recipients who make a poor recovery and die soon after operation.
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We have reviewed all perioperative deaths in adults up to the tenth postoperative day to determine if such platelet thrombi are a common finding in transplant related deaths or if they are a more generalised finding in patients dying suddenly during, or after, other operations. during resuscitation), 4, and 5. During the The average age of the non-transplant anhepatic stage of the operation there was an group was 69 years (range 24-89 years), expected fall in cardiac output with a comseven men and six women. Death occurred pensatory rise in peripheral resistance. Venofrom day 0 to day 6 postoperatively. The 24 venous bypass was not used. In those patients year old woman with amniotic fluid embolism who died during surgery there was a sudden (case 7) was about to die before surgery and and unrecoverable loss of cardiac output. In underwent an emergency hysterectomy in an the patient with pre-existing pulmonary attempt to save her child. All other patients hypertension (case 2) this occurred before the were considered fit for anaesthetic.
Methods
donor liver was revascularised. In patients surviving for a few days after operation no PEROPERATIVE OBSERVATIONS catastrophic intraoperative event was In an attempt to reduce intraoperative blood observed but they required increasing post- 
MACROSCOPIC APPEARANCES OF THE LUNGS
There were notable differences between the lungs from patients who had undergone liver transplantation compared with other operations. In liver transplant recipients the lungs were heavy, with an average weight of 878 g and a range of 700-1250 g. The consistency was unusually rubbery and appeared congested, much like the appearance of lungs seen in adult respiratory distress syndrome. Despite the weight of the lungs, pulmonary oedema could not be easily expressed from the tissues. Macroscopic pulmonary emboli were not identified in any of the patients.
In six patients who had died after other operations, the appearances of the lungs were normal with weights of 250-450 g. Seven patients had noticeable pulmonary oedema with fluid easily expressed from the tissues and weights of 500-900 g. In two cases thromboemboli were identified macroscopically in large vessels.
MICROSCOPIC APPEARANCES
Sections of lung from liver transplant recipients, particularly those who had died suddenly during the operation, showed congested and dilated capillaries with extensive intravascular thrombi occluding small arterioles and alveolar capillaries of all lobes. These thrombi appeared eosinophilic or slightly basophilic with a granular or fine fibrillary texture on haematoxylin and eosin staining (fig 1) . These capillary thrombi showed positive immunostaining for platelet markers, factor XIIIA, and PGIIIa (fig 2) . Some thrombi contained irregular, granular basophilic material reminiscent of cell debris, admixed with leucocytes. Staining for glycogen, reticulin and immunostaining with CAM 5-2 and MNF116 failed to identify admixed fragments resembling hepatic or biliary tissue in the thrombi. Occasional large and medium sized arteries were partially occluded by similar thrombus. Immunostaining for fibrinogen was seen in many large and medium sized arteries and some capillaries containing thrombus. This was in contrast to the localisation of factor XIIIA and PGIIIa immunostaining which was present almost exclusively in alveolar capillaries and small arterioles. The wide extent of the intravascular thrombosis was emphasised by this staining technique. Tissue prepared for electron microscopy was suboptimally preserved due to post mortem autolysis, but no features resembling hepatocyte cytoplasm were identified admixed with thrombus. No other organs showed similar fibrin or platelet thrombi.
The donor livers were examined in each case and appeared normal apart from that in case 1. This showed severe fatty change and some haemorrhage which was more than is normally encountered in baseline biopsy specimens.
In addition to the above changes, case 2 showed mild and patchy features of fibrosing alveolitis and rather pronounced focal cryptogenic organising pneumonitis (COP). The pulmonary arteries showed intimal thickening and medial hypertrophy in keeping with pulmonary hypertension. In contrast to the liver transplant recipients, lungs from non-transplant patients showed less congestion and more pulmonary oedema. Only two of the four patients who died suddenly on the day of the operation showed widespread capillary thrombi (cases 7 and 8). One patient had DIC, the other had cement hypotension syndrome. A second patient dying of cement hypotension syndrome showed only moderate numbers of capillary plugs (case 9). These thrombi immunostained positively for factor XIIIA and PGIIIa. The three patients who had died of cement hypotension syndrome (cases 8, 9, and 17) all showed extensive fat emboli within small pulmonary capillaries. Patients dying later rarely showed positive immunostaining in capillaries. A fall in the intraoperative platelet count was seen in all cases. In most cases this appeared small, however, the counts represented a random sample taken at the start of the operation and did not reflect the true peripheral blood count after haemodynamic collapse of the patient. In case 3 resuscitation was prolonged and visible consumption of platelets was seen as the counts fell from 178 to 50 x 109/1 over three hours. During this time 10 Units of platelets were transfused. Most patients who survived several days after surgery received platelet infusions (cases 4 and 5) and eventually developed a recognisable coagulopathy terminally with evidence of fibrinogen degradation products (cases 4 and 6). 
Discussion
This study has shown that there is a high incidence of platelet microemboli in the lungs of patients who die suddenly during operation. Non-transplant patients who showed these changes had a known coagulopathy or recognised risk of embolic disease.' Patients undergoing liver transplantation had no known similar risk factors, yet developed widespread and fatal pulmonary thrombosis. The platelet thrombi predominantly occluded small pulmonary capillaries and were admixed with variable amounts of fibrin. Similar thrombi were less common in postoperative deaths, although they occurred in liver transplant recipients up to eight days after transplantation. They were not found in other organs of the body in transplant recipients and thus did not seem to represent part of a more widespread disseminated intravascular coagulation (DIC). In patients dying acutely, the sudden and profound fall in cardiac output, associated, in most cases with a considerably raised pulmonary arterial pressure, suggested that intrapulmonary obstruction by thrombi explained the failure of resuscitation attempts.
Interpretation of the fall in platelet counts is difficult and complicated by several factors. The samples were random and do not reflect counts immediately after surgery or after haemodynamic collapse of the patient, except in case 3. In this case repeated blood counts during resuscitation documented a clear consumption of platelets before death. In the patients surviving several days, postoperative factors, such as further surgery for haemorrhage, differing numbers of platelet infusions, and the development of a recognisable coagulopathy terminally, make interpretation inaccurate and detract from the fact that the patients were haemodynamically unstable immediately after surgery.
The cause of massive, widespread activation of platelet aggregation in liver transplant recipients is unclear. One possibility is that release of tissue thromboplastin or cell debris from the ischaemic donor liver may activate platelet aggregation and lead to microembolism. Tissue thromboplastin and activated thrombin have been shown to produce pulmonary microembolism in experimental animals.5-8 The baseline biopsy specimen appearances of only one donor liver (case 1) showed extensive fatty change compatible with ischaemia; the others were unremarkable. In an attempt to reduce this effect the donor liver is flushed with albumin solution before reperfusion. Patients who arrest at the time of reperfusion due to a combination of cold, acidotic, and hyperkalaemic fluid entering the circulation are usually successfully resuscitated. In case 2 cardiovascular collapse occurred before revascularisation of the donor liver. No thromboplastin or cell debris would have entered the circulation of this patient. Specific staining for hepatocytes or biliary epithelium failed to identify cell debris within pulmonary capillaries of any of the patients. Gosseye et al. also failed to demonstrate cell debris within capillaries in children dying during liver transplantation. ' Many animal studies have demonstrated the ability of injected endotoxin9-" to cause platelet thrombi within the lungs. A study performed by Miyata et al2 showed an accumulation of endotoxin during the anhepatic stage in patients undergoing liver transplantation. This did not correlate with the duration of the anhepatic stage but did correlate with the need for perioperative platelet transfusions, ventilator dependency postoperatively, and one month case fatality. From these clinical data it seems likely that endotoxin caused platelet consumption and aggregation in the lungs of these patients, but the histological appearance of the lungs was not documented. This mechanism of platelet aggregation would not require the reconnection of the donor liver to produce an effect and may offer an explanation for our observations.
Cross-clamping of the aorta during emergency surgery has been shown to lead to a raised incidence of pulmonary microembolism.2 Similar experimental procedures on animals cause a significant fall in serum fibrinogen and result in some fibrin and numerous platelet thrombi and aggregates within the lungs."I '4 The mechanism is poorly understood but thrombosis in these cases was thought to occur within the inferior vena cava as a result of trauma to the endothelium and stasis.'4 During liver transplantation the inferior vena cava is cross-clamped and some degree of endothelial trauma and circulatory stasis are unavoidable. This mechanism may have contributed to thrombus formation in our patients, although it cannot explain the formation of platelet aggregates in case 2 who collapsed before release of the inferior vena cava clamp. This patient also had additional pulmonary pathology, and an alternative, possibly local, mechanism of activation may have occurred.
Hypoxia,'5 metabolic acidosis,'6 and chronic lung disease'7 may result in a local activation of platelet aggregation in the lungs. This is unlikely to have contributed in our cases except in case 2, as particular care was taken to maintain a stable acid base status and oxygen delivery during transplantation.
Platelet thrombi may form extremely rapidly. Stimulation of a-adrenergic receptors in mice resulted in the accumulation of platelet aggregates in the lungs within 10 seconds.'8 Other mechanisms may take several minutes or hours. It was two hours before fibrin thrombi were detected following immune complex mediated DIC,'9 and it is unlikely that this mechanism would explain the formation of microthrombi seen in our patients.
Patients with liver disease are prone to develop microthrombi.20 A necropsy study by Oka et al20 showed that 50-60% of patients with various different liver diseases had microthrombi and classic thrombi in one or more organs. Patients with portal hypertension are also at increased risk of developing pulmonary hypertension,2' one of the postulated mechanisms being recurrent microemboli. During liver transplantation the coagulation status of patients is monitored using serial thromboelastography. No evidence of hypercoagulability was identified in our patients at any stage. Antifibrinolytic drugs were used during surgery to reduce blood loss in patients with abnormal clotting variables. No thrombotic complications have previously been reported with this drug. Three of the six patients in our study did not receive this drug and none of the children in the study by Gosseye et aP was given a similar drug. It is unlikely that this drug alone explains the sequestration of platelet aggregates in the lungs.
Several mechanisms of platelet aggregation may act synergistically in liver transplant recipients and the phenomenon may only become evident clinically when it occurs on such a scale as to cause severe respiratory distress or death. It probably occurs more frequently on a smaller scale with the high fibrinolytic activity of the human lung,22 making it of less clinical consequence. Further studies are needed to try and identify those patients who are at particular risk and to avoid any procedures which may precipitate platelet aggregation. The lack of visible thrombus at necropsy may cause the unwary pathologist to dismiss the possibility of thrombosis, but the unusual rubbery consistency and increased weight of the lungs without easily demonstrable pulmonary oedema should alert them to sample the lungs widely and make a detailed search for capillary thrombi. Immunostaining with factor XIIIA and PGIIIa considerably aid the identification of these thrombi.
